Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Menlo Therapeutics' cough drug fails to meet primary endpoint in phase II trial

pharmafileNovember 20, 2018

Tag: Menlo Therapeutics , Steve Basta , chronic cough

PharmaSources Customer Service